CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
Top Cited Papers
Open Access
- 15 August 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (7), 1316-1324
- https://doi.org/10.1182/blood-2013-02-487074
Abstract
Key Points CMV reactivation after HCT is associated with a reduced risk of early relapse in patients with AML but not other disease groups. The benefit, however, is offset by an increased risk of nonrelapse mortality.Keywords
This publication has 29 references indexed in Scilit:
- NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRsBlood, 2013
- Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipientsBone Marrow Transplantation, 2012
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent functionBlood, 2012
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell LymphomaCancer Cell, 2011
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsBlood, 2011
- Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive TherapyTransplantation and Cellular Therapy, 2009
- Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblastsBlood, 2006
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infectionBritish Journal of Haematology, 1986